| Adaptive Prosthetic And Orthotic Te | |
| 190 Quincy Ave, Brockton, Massachusetts 02302 | |
| (508) 587-7300 |
| Name | Adaptive Prosthetic And Orthotic Te |
|---|---|
| Organization Name | Adaptive Prosthetic And Orthotic Technologies, Inc. |
| Location | 190 Quincy Ave, Brockton, Massachusetts 02302 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (508) 587-7300 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Scientists have developed a novel plastic surface which overcomes the difficulties associated with growing adult stem cells. Standard surfaces have proved limited for growing large amounts and retaining the stem cells' useful characteristics. This discovery could lead to the creation of stem cell therapies for re-growing bone and tissue, and also for conditions such as arthritis. The study was carried out by Glasgow and Southampton universities.
NewLink Genetics Corporation, a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the initiation of a double-blind, randomized, placebo-controlled Phase 2 clinical study of its first IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, indoximod, in patients with metastatic breast cancer.
Adult patients with diabetes who trust their medical provider and feel included in treatment decisions are significantly more likely to take and maintain a newly prescribed antidepressant medication, according to a new study in the Journal of General Internal Medicine.
Prostate cancer is the most frequent and second deadliest cancer men face. A team of Wayne State University researchers recently received $363,660 from the National Cancer Institute of the National Institutes of Health for the project - "Bone-induced c-kit in prostate cancer cells: implications for bone metastasis" - that aims to shed new light on implications for bone metastasis in prostate cancer.
› Verified 4 days ago
| NPI Number | 1114095544 |
| Organization Name | ADAPTIVE PROSTHETIC AND ORTHOTIC TECHNOLOGIES, INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 190 Quincy Ave, Brockton, MA 02302 |
| Phone Number | 508-587-7300 |
News Archive
Scientists have developed a novel plastic surface which overcomes the difficulties associated with growing adult stem cells. Standard surfaces have proved limited for growing large amounts and retaining the stem cells' useful characteristics. This discovery could lead to the creation of stem cell therapies for re-growing bone and tissue, and also for conditions such as arthritis. The study was carried out by Glasgow and Southampton universities.
NewLink Genetics Corporation, a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the initiation of a double-blind, randomized, placebo-controlled Phase 2 clinical study of its first IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, indoximod, in patients with metastatic breast cancer.
Adult patients with diabetes who trust their medical provider and feel included in treatment decisions are significantly more likely to take and maintain a newly prescribed antidepressant medication, according to a new study in the Journal of General Internal Medicine.
Prostate cancer is the most frequent and second deadliest cancer men face. A team of Wayne State University researchers recently received $363,660 from the National Cancer Institute of the National Institutes of Health for the project - "Bone-induced c-kit in prostate cancer cells: implications for bone metastasis" - that aims to shed new light on implications for bone metastasis in prostate cancer.
› Verified 4 days ago
| NPI Number | 1316176548 |
| Organization Name | SYNERGY DME, INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 790 W Chestnut St, Brockton, MA 02301 |
| Phone Number | 508-587-7300 |
News Archive
Scientists have developed a novel plastic surface which overcomes the difficulties associated with growing adult stem cells. Standard surfaces have proved limited for growing large amounts and retaining the stem cells' useful characteristics. This discovery could lead to the creation of stem cell therapies for re-growing bone and tissue, and also for conditions such as arthritis. The study was carried out by Glasgow and Southampton universities.
NewLink Genetics Corporation, a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the initiation of a double-blind, randomized, placebo-controlled Phase 2 clinical study of its first IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, indoximod, in patients with metastatic breast cancer.
Adult patients with diabetes who trust their medical provider and feel included in treatment decisions are significantly more likely to take and maintain a newly prescribed antidepressant medication, according to a new study in the Journal of General Internal Medicine.
Prostate cancer is the most frequent and second deadliest cancer men face. A team of Wayne State University researchers recently received $363,660 from the National Cancer Institute of the National Institutes of Health for the project - "Bone-induced c-kit in prostate cancer cells: implications for bone metastasis" - that aims to shed new light on implications for bone metastasis in prostate cancer.
› Verified 4 days ago
News Archive
Scientists have developed a novel plastic surface which overcomes the difficulties associated with growing adult stem cells. Standard surfaces have proved limited for growing large amounts and retaining the stem cells' useful characteristics. This discovery could lead to the creation of stem cell therapies for re-growing bone and tissue, and also for conditions such as arthritis. The study was carried out by Glasgow and Southampton universities.
NewLink Genetics Corporation, a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the initiation of a double-blind, randomized, placebo-controlled Phase 2 clinical study of its first IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, indoximod, in patients with metastatic breast cancer.
Adult patients with diabetes who trust their medical provider and feel included in treatment decisions are significantly more likely to take and maintain a newly prescribed antidepressant medication, according to a new study in the Journal of General Internal Medicine.
Prostate cancer is the most frequent and second deadliest cancer men face. A team of Wayne State University researchers recently received $363,660 from the National Cancer Institute of the National Institutes of Health for the project - "Bone-induced c-kit in prostate cancer cells: implications for bone metastasis" - that aims to shed new light on implications for bone metastasis in prostate cancer.
› Verified 4 days ago
Cvs Pharmacy #11268 Type: Medicare Supplier Location: 63 Main St, Brockton, Massachusetts 02301 Phone: (508) 580-3000 | |
Cvs Pharmacy # 01250 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 555 Belmont Street, Brockton, Massachusetts 02301 Phone: (508) 586-7988 | |
Cvs Pharmacy # 01008 Type: Medicare Supplier Location: 230 E Ashland Street, Brockton, Massachusetts 02302 Phone: (508) 580-0180 | |
Cvs Pharmacy #01248 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 240 Oak St, Brockton, Massachusetts 02301 Phone: (508) 588-4610 | |
Cvs Pharmacy # 01007 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1267 Main St, Brockton, Massachusetts 02301 Phone: (508) 587-0235 |